QR Code

Edaravone and Acetovanillone Upregulate Nrf2 and PI3K/Akt/mTOR Signaling and Prevent Cyclophosphamide Cardiotoxicity in Rats

Emad HM Hassanein,1 Omnia AM Abd El-Ghafar,2 Marwa A Ahmed,3 Ahmed M Sayed,4 Wail M Gad-Elrab,5 Jamaan S Ajarem,6 Ahmed A Allam,7 Ayman M Mahmoud7,8 1Department of Pharmacology and Toxicology Faculty of Pharmacy, Al-Azhar University, Assiut, Egypt; 2Department of Pharmacology and Toxicology, Faculty...

Whakaahuatanga katoa

I tiakina i:
Ngā kaituhi matua: Hassanein EHM, Abd El-Ghafar OAM, Ahmed MA, Sayed AM, Gad-Elrab WM, Ajarem JS, Allam AA, Mahmoud AM
Hōputu: Artigo
Reo:Inglês
I whakaputaina: Dove Medical Press 2020-11-01
Rangatū:Drug Design, Development and Therapy
Ngā marau:
chemotherapy
acetovanillone
edaravone
oxidative stress
cardiotoxicity
nrf2
mtor.
Urunga tuihono:https://www.dovepress.com/edaravone-and-acetovanillone-upregulate-nrf2-and-pi3kaktmtor-signaling-peer-reviewed-article-DDDT
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite